Business

The US Onychomycosis Market Healthcare, Clinical Reviews, Survey Report 2019 to 2023

The US Onychomycosis Market: Size, Trends & Forecasts (2019-2023 Edition)

The report provides a unique tool for evaluating the market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments, and focuses on markets, capacities and technologies, and on the changing structure of the Onychomycosis.

Purchase a Copy of This Report (USD $850):

https://www.marketinsightsreports.com/report/purchase/08271427334?mode=su?source=xherald&Mode=07

Top Leading Companies of The US Onychomycosis Market are Bausch Health Companies (Formerly Valeant Pharmaceuticals), Pfizer, Inc., Johnson and Johnson, Novartis AG and others.

The leading players of Onychomycosis industry, their market share, product portfolio, company profiles are covered in this report. The leading market players are analyzed on the basis of production volume, gross margin, market value, and price structure. The competitive market scenario among Onychomycosis players will help the industry aspirants in planning their strategies. The statistics offered in this report will be precise and useful guide to shape the business growth.

Get Sample Copy of this Report:

https://www.marketinsightsreports.com/reports/08271427334/the-us-onychomycosis-market-size-trends-forecasts-2019-2023-edition/inquiry?source=xherald&Mode=07

Executive Summary:

Onychomycosis is a condition of fungal nail infection. Onychomycosis begins in the nail bed and progresses to the nail plate, causing the nail to become discolored, deformed, and even separated from the nail bed. Onychomycosis has a significant chance of reoccurrence. Of all the nail abnormalities in the world, around 50% are the case of onychomycosis. In most of the cases it occurs in the toenails. Onychomycosis is not a life threatening disease but, may persist or worsen if not treated.

Symptoms of onychomycosis are changes in appearance of the nail, interference with standing, walking, and exercising, pain, discomfort, etc. The causative pathogens of onychomycosis include dermatophytes (most common), Candida, and nondermatophytic molds.

There are five types of Onychomycosis: Distal Subungual Onychomycosis, White superficial onychomycosis, Proximal subungual onychomycosis, Endonyx onychomycosis and Candidal onychomycosis. Two types of treatments are available of onychomycosis: Oral Treatment and Topical Treatment. Oral treatment includes: Terbinafine, Itraconazole, etc. and topical treatment includes Kerydin, Jublia, etc. Nonpharmacologic approaches are also there, which includes the following: Laser treatment, Photodynamic therapy, etc.

The US onychomycosis market is forecasted to grow at a healthy growth rate during the forecast period (2019-2023). The US onychomycosis market is supported by various growth drivers, such as rising per capita healthcare expenditure, increasing diabetic patients, ageing population, introduction of new drugs, etc. Yet, the market faces certain challenges, such as, reimbursements, low awareness, side effects, etc.

Explore Full Report With Detailed TOC Here:

https://www.marketinsightsreports.com/reports/08271427334/the-us-onychomycosis-market-size-trends-forecasts-2019-2023-edition?source=xherald&Mode=07

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides The US and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:

Irfan Tamboli (Head of Sales) – Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

sales@marketinsightsreports.com | irfan@marketinsightsreports.com

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close